FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2066398399> ?p ?o ?g. }

• W2066398399 endingPage "256" @default.
• W2066398399 startingPage "249" @default.
• W2066398399 abstract "Patients with homozygous familial hypercholesterolaemia (HFH) have abnormalities in both low-density lipoprotein (LDL) receptor alleles, resulting in severe hypercholesterolaemia and premature coronary heart disease. Limited treatment options are available and the response to drug therapy has been poor. In the present paper, we have evaluated the efficacy and safety of simvastatin at doses beyond the current maximal dose of 40 mg/day in patients with HFH. After a 4 week placebo diet run-in period, 12 patients with well-characterized HFH were randomized to simvastatin 80 mg/day administered in three divided doses (n = 8; group 1) or 40 mg once daily (n = 4; group 2). After 9 weeks, the dose in group 1 was increased to 160 mg/day while the dose in group 2 was kept at 40 mg/day, but with the drug given in three divided doses and treatment continued for an additional 9 weeks. All 12 patients completed the study and there were no serious or unexpected adverse effects. LDL-cholesterol concentrations fell by 14% at the 40 mg/day dose, but were reduced further at the higher doses (25% at the 80 mg/day and by 31% at the 160 mg/day dosage, P < 0.0001). Excretion of urinary mevalonic acid, as an index of in vivo cholesterol biosynthesis, was reduced but did not correlate with reduction in LDL-cholesterol in the individual patients. The magnitude of response to therapy was not predicted by the LDL-receptor gene defect as patients with the same LDL-receptor mutations responded differently to the same dose of simvastatin therapy. The ability of expanded doses of simvastatin (80 or 160 mg/day) to reduce LDL-cholesterol levels in patients with HFH, even if receptor negative, suggests that at these doses, the drug reduces LDL production. Simvastatin therapy, at doses of 80 or 160 mg/day, should therefore be considered in all patients with HFH, either as an adjunct to apheresis, or as monotherapy for those patients who do not have access to apheresis or other such treatment modalities." @default.
• W2066398399 created "2016-06-24" @default.
• W2066398399 creator A5009712941 @default.
• W2066398399 creator A5018502840 @default.
• W2066398399 creator A5041403685 @default.
• W2066398399 creator A5044425699 @default.
• W2066398399 creator A5049272753 @default.
• W2066398399 creator A5053166045 @default.
• W2066398399 creator A5073233494 @default.
• W2066398399 creator A5078703362 @default.
• W2066398399 date "1997-12-01" @default.
• W2066398399 modified "2023-09-23" @default.
• W2066398399 title "Expanded-dose simvastatin is effective in homozygous familial hypercholesterolaemia" @default.
• W2066398399 cites W1836063392 @default.
• W2066398399 cites W1844308307 @default.
• W2066398399 cites W2000322053 @default.
• W2066398399 cites W2016678257 @default.
• W2066398399 cites W2024318154 @default.
• W2066398399 cites W2045175568 @default.
• W2066398399 cites W2045408341 @default.
• W2066398399 cites W2047933207 @default.
• W2066398399 cites W2048136153 @default.
• W2066398399 cites W2048895138 @default.
• W2066398399 cites W2057394745 @default.
• W2066398399 cites W2060132183 @default.
• W2066398399 cites W2062723580 @default.
• W2066398399 cites W2070079873 @default.
• W2066398399 cites W2071124826 @default.
• W2066398399 cites W2084744450 @default.
• W2066398399 cites W2087714109 @default.
• W2066398399 cites W2088205396 @default.
• W2066398399 cites W2091146995 @default.
• W2066398399 cites W2093535758 @default.
• W2066398399 cites W2102953109 @default.
• W2066398399 cites W2103658595 @default.
• W2066398399 cites W2106097609 @default.
• W2066398399 cites W2115598881 @default.
• W2066398399 cites W2116404316 @default.
• W2066398399 cites W2118310760 @default.
• W2066398399 cites W2118728926 @default.
• W2066398399 cites W2121653626 @default.
• W2066398399 cites W2123179341 @default.
• W2066398399 cites W2155598961 @default.
• W2066398399 cites W2314936871 @default.
• W2066398399 cites W4230933063 @default.
• W2066398399 cites W4242270365 @default.
• W2066398399 cites W81463456 @default.
• W2066398399 doi "https://doi.org/10.1016/s0021-9150(97)00168-8" @default.
• W2066398399 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9430375" @default.
• W2066398399 hasPublicationYear "1997" @default.
• W2066398399 type Work @default.
• W2066398399 sameAs 2066398399 @default.
• W2066398399 citedByCount "87" @default.
• W2066398399 countsByYear W20663983992012 @default.
• W2066398399 countsByYear W20663983992013 @default.
• W2066398399 countsByYear W20663983992014 @default.
• W2066398399 countsByYear W20663983992015 @default.
• W2066398399 countsByYear W20663983992016 @default.
• W2066398399 countsByYear W20663983992017 @default.
• W2066398399 countsByYear W20663983992018 @default.
• W2066398399 countsByYear W20663983992019 @default.
• W2066398399 countsByYear W20663983992020 @default.
• W2066398399 countsByYear W20663983992022 @default.
• W2066398399 crossrefType "journal-article" @default.
• W2066398399 hasAuthorship W2066398399A5009712941 @default.
• W2066398399 hasAuthorship W2066398399A5018502840 @default.
• W2066398399 hasAuthorship W2066398399A5041403685 @default.
• W2066398399 hasAuthorship W2066398399A5044425699 @default.
• W2066398399 hasAuthorship W2066398399A5049272753 @default.
• W2066398399 hasAuthorship W2066398399A5053166045 @default.
• W2066398399 hasAuthorship W2066398399A5073233494 @default.
• W2066398399 hasAuthorship W2066398399A5078703362 @default.
• W2066398399 hasConcept C10146269 @default.
• W2066398399 hasConcept C126322002 @default.
• W2066398399 hasConcept C134018914 @default.
• W2066398399 hasConcept C142724271 @default.
• W2066398399 hasConcept C197934379 @default.
• W2066398399 hasConcept C204787440 @default.
• W2066398399 hasConcept C27081682 @default.
• W2066398399 hasConcept C2776329913 @default.
• W2066398399 hasConcept C2778163477 @default.
• W2066398399 hasConcept C2779120738 @default.
• W2066398399 hasConcept C2780072125 @default.
• W2066398399 hasConcept C43554185 @default.
• W2066398399 hasConcept C71924100 @default.
• W2066398399 hasConcept C90924648 @default.
• W2066398399 hasConceptScore W2066398399C10146269 @default.
• W2066398399 hasConceptScore W2066398399C126322002 @default.
• W2066398399 hasConceptScore W2066398399C134018914 @default.
• W2066398399 hasConceptScore W2066398399C142724271 @default.
• W2066398399 hasConceptScore W2066398399C197934379 @default.
• W2066398399 hasConceptScore W2066398399C204787440 @default.
• W2066398399 hasConceptScore W2066398399C27081682 @default.
• W2066398399 hasConceptScore W2066398399C2776329913 @default.
• W2066398399 hasConceptScore W2066398399C2778163477 @default.
• W2066398399 hasConceptScore W2066398399C2779120738 @default.
• W2066398399 hasConceptScore W2066398399C2780072125 @default.
• W2066398399 hasConceptScore W2066398399C43554185 @default.

• next